Return to search

Ray Therapeutics snags $6m seed

Ray Therapeutics, a developer of optogenetic gene therapies for patients with blinding diseases, has raised $6 million in seed financing.

Ray Therapeutics, a developer of optogenetic gene therapies for patients with blinding diseases, has raised $6 million in seed financing. The lead backer was 4Bio Capital.

Source: Press Release